Skip regulates TGF- β 1-induced extracellular matrix degrading proteases expression in human PC-3 prostate cancer cells
Author
dc.contributor.author
Villar, Victor
Author
dc.contributor.author
Kocic, Jelena
Author
dc.contributor.author
Santibanez, Juan F.
Admission date
dc.date.accessioned
2019-03-18T11:55:00Z
Available date
dc.date.available
2019-03-18T11:55:00Z
Publication date
dc.date.issued
2013
Cita de ítem
dc.identifier.citation
Prostate Cancer, Volumen 2013,
Identifier
dc.identifier.issn
2090312X
Identifier
dc.identifier.issn
20903111
Identifier
dc.identifier.other
10.1155/2013/398253
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/166904
Abstract
dc.description.abstract
Purpose. To determine whether Ski-interacting protein (SKIP) regulates TGF-β1-stimulated expression of urokinase-type plasminogen activator (uPA), matrix metalloproteinase-9 (MMP-9), and uPA Inhibitor (PAI-1) in the androgen-independent human prostate cancer cell model. Materials and Methods. PC-3 prostate cancer cell line was used. The role of SKIP was evaluated using synthetic small interference RNA (siRNA) compounds. The expression of uPA, MMP-9, and PAI-1 was evaluated by zymography assays, RT-PCR, and promoter transactivation analysis. Results. In PC-3 cells TGF-β1 treatment stimulated uPA, PAI-1, and MMP-9 expressions. The knockdown of SKIP in PC-3 cells enhanced the basal level of uPA, and TGF-β1 treatment inhibited uPA production. Both PAI-1 and MMP-9 production levels were increased in response to TGF-β1. The ectopic expression of SKIP inhibited both TGF-β1-induced uPA and MMP-9 promoter transactivation, while PAI-1 promoter response to the factor was unaffected. Conclusions.